This study is designed to:
1. assess the signs and symptoms of rosacea, including erythema, without treatment and
during treatment with Mirvaso® gel
2. further characterize lifestyle impact and patient satisfaction with Mirvaso® treatment
3. gain a better understanding of the real-world use of Mirvaso® on the pattern and
management of facial erythema of rosacea.
Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea
Completed
Watson Laboratories, Inc.
Phase 3
2014-07-01
A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel-Design Study to
Evaluate the Safety and Therapeutic Equivalence of Brimonidine Topical Gel, 0.33% (Watson
Laboratories, Inc., USA) to Reference Product Mirvaso® (brimonidine) topical gel, 0.33%
(Galderma Laboratories, L.P., USA) in Patients with Moderate to Severe Facial Erythema
Associated with Rosacea
Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea
Completed
Actavis Inc.
Phase 3
2014-07-01
A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel-Design Study to
Evaluate the Safety and Therapeutic Equivalence of Brimonidine Topical Gel, 0.33% (Watson
Laboratories, Inc., USA) to Reference Product Mirvaso® (brimonidine) topical gel, 0.33%
(Galderma Laboratories, L.P., USA) in Patients with Moderate to Severe Facial Erythema
Associated with Rosacea
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
